Adults over the age of 60 are recommended not to get the chikungunya vaccine to prevent the mosquito-borne illness due to two ...

The FDA and CDC recommended a pause for Ixchiq, a chikungunya vaccine, following reports of adverse events in recipients 60 ...

The Trump administration has launched a $500 million project to develop a universal flu vaccine that won't need yearly ...

TUESDAY, May 13, 2025 (HealthDay News) — U.S. health officials are telling travelers aged 60 and older to avoid a chikungunya ...

UW Health's Dr. Jeff Pothof discusses FDA-approved food dyes, a new tool to test for HPV at home and the shingles vaccine.

A half-decade since the pandemic, countless individuals and families have been left wondering: what is the long-term safety ...

San Diego-based RNA biotech Arcturus is doubling down on mRNA therapeutics and stepping back from earlier-stage vaccine work ...

The National Institute of Allergy and Infectious Diseases (NIAID) plans to initiate phase 1 clinical trial of Capricor's ...

Dr. Oz, Administrator of the Centers for Medicare & Medicaid Services, joins MSNBC’s Ari Melber for an extended conversation ...

The U.S. government is advising that international travelers age 60 and older not get a chikungunya vaccine as it ...

Actively screening for the 10,000 participant portion of COVID-19 Phase 2b trial; Dosing expected to begin in second quarter of 2025 Completed enrollment of Phase 1 clinical trial evaluating Company’s ...

The administration’s “pronatalist” position is substantially at odds with a range of policy decisions that will cause kids to ...